Neovacs appoints Miguel Sieler as CEO

– FRANCE, Paris – NEOVACS (Alternext Paris : ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases, announced today that Miguel Sieler, former Chairman and Chief Executive Officer of Bayer France has been named Chief Executive Officer of Neovacs, replacing Guy-Charles Fanneau De La Horie.…

Monitise appoints Steve Chambers as Non-Executive Director

– UK, London – Monitise (LSE: MONI) is pleased to announce the appointment of the new Visa Europe representative to the Group’s Board, with Steve Chambers joining as Non-Executive Director, effective immediately.…